Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Safety and Pharmacokinetic Study of Single Agent REGN2810 in Pediatric Patients With Relapsed or Refractory Solid or Central Nervous System (CNS) Tumors and a Safety and Efficacy Trial of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma, Newly Diagnosed High-Grade Glioma, or Recurrent High-Grade Glioma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03690869
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:38.015218+00:00
Published At
2024-10-09T00:00:00+00:00
Record Updated At
2025-04-08
Results Posted At
2024-10-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Relapsed Solid Tumor", "Refractory Solid Tumor", "Relapsed Central Nervous System Tumor", "Refractory Central Nervous System Tumor", "Diffuse Intrinsic Pontine Glioma", "High Grade Glioma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-04-08"
protocolSection.identificationModule.nctId
"NCT03690869"
protocolSection.identificationModule.officialTitle
"A Safety and Pharmacokinetic Study of Single Agent REGN2810 in Pediatric Patients With Relapsed or Refractory Solid or Central Nervous System (CNS) Tumors and a Safety and Efficacy Trial of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma, Newly Diagnosed High-Grade Glioma, or Recurrent High-Grade Glioma"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-10-09"

Study condition terms

  • Relapsed Solid Tumor (protocolSection.conditionsModule.conditions)
  • Refractory Solid Tumor (protocolSection.conditionsModule.conditions)
  • Relapsed Central Nervous System Tumor (protocolSection.conditionsModule.conditions)
  • Refractory Central Nervous System Tumor (protocolSection.conditionsModule.conditions)
  • Diffuse Intrinsic Pontine Glioma (protocolSection.conditionsModule.conditions)
  • High Grade Glioma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.